Actively Recruiting
WAMIF: Prospective Cohort Follow-Up Study of Young Women Presenting Acute Myocardial Infarction in France with Clinical, Morphological, and Biological Analysis
Led by French Cardiology Society · Updated on 2026-01-12
314
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are following up on the WAMIF study, which initially collected detailed clinical, morphological, and biological data on women under 50 who experienced acute myocardial infarction (heart attack). The original study included 314 women across 30 centers in France from 2017 to 2019 and assessed their short-term and 12-month outcomes. The follow-up aims to extend monitoring beyond 12 months to better understand long-term prognosis and improve care for these patients, focusing especially on women under 50 years old who had a heart attack. This follow-up study involves collecting information about major health events since the original WAMIF study participation and assessing patients' stress, anxiety, depression, and quality of life using validated questionnaires such as PSS-4, GAD-7, PHQ-9, EQ-5D, and SF-12. All patients who took part in the initial WAMIF study and wish to continue are eligible for this observational cohort follow-up. Participants will be monitored for major outcomes including death from any cause, cardiovascular death, stent thrombosis, stroke, recurrent heart attack, emergency revascularization, major bleeding, emergency hospitalization for heart failure, and emergency department visits over a 5 to 10 year period after their initial study involvement. Mental health and quality of life scores will also be evaluated during this extended follow-up. This long-term observation will help provide fundamental data on health and well-being for young women after a heart attack.
CONDITIONS
Brief Title
WAMIF: Prospective Study in Young Women Presenting Acute Myocardial Infarction: Cohort Follow up
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients who participated in the original WAMIF study (NCT03073447)
- Aged between 18 and 60 years
- Willing to continue follow-up in this study
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for eligibility confirmation
Duration - 5 to 10 years after participation in the original WAMIF study
Participants who took part in the original WAMIF study are followed up to collect information on major cardiovascular events and assess their mental health and quality of life.
Periodic assessments including questionnaires and event collection; visit frequency varies depending on participant availability
Trial Site Locations
Total: 1 location
1
Hôpital de la Pitié Salpétrière
Paris, France, 75012
Actively Recruiting
Research Team
T
Tessa BERGOT, MSc
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here